Skip to main content

Table 2 Incidence rate ratio estimates for the considered interventions based on pair-wise meta-analysis (PMA) and network meta-analysis (NMA)

From: The impact of incorporating Bayesian network meta-analysis in cost-effectiveness analysis - a case study of pharmacotherapies for moderate to severe COPD

Intervention

Rate ratios (95% CrI)

PMA

NMA

Placebo

  

ICS

0.81 (0.68-0.95)

0.81 (0.72-0.91)

LABA

0.87 (0.75-1.01)

0.87 (0.78-0.96)

ICS + LABA

0.71 (0.60-0.88)

0.70 (0.62-0.79)

LAMA

0.73 (0.59-0.91)

0.74 (0.67-0.82)

  1. PTC: pairwise treatment comparison, MTC: multiple treatment comparison, CrI: credible interval.
Back to article page

Cost Effectiveness and Resource Allocation

ISSN: 1478-7547

Contact us